Current understanding and future directions in severe asthma through artificial intelligence-integrated multi-omic approaches.

Abstract excerpt

Severe asthma remains a challenging, heterogeneous condition, despite significant advances in therapeutic strategies. A subset of patients continues to experience poor control, frequent exacerbations and a high burden of disease. The advent of multi-omic technologies, including genomics, transcriptomics, proteomics and metabolomics, has opened new avenues for understanding the molecular underpinnings of asthma....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Anti-Asthmatic Agents
• Share to Artificial Intelligence